Bristol-Myers Directors Sued in NY Over FCPA Inaction
An investor has launched a derivative suit in New York alleging that directors of Bristol-Myers Squibb Co. failed to respond to warning signs that its representatives in China were bribing state-owned...To view the full article, register now.
Already a subscriber? Click here to view full article